HB 2556 (see companion bill SB 5995) – Washington

Status: Inactive / Dead
Year Introduced: 2018
Link: http://apps2.leg.wa.gov/billsummary?BillNumber=2556&Chamber=House&Year=2017

GENERIC PRESCRIPTION DRUG PRICES: Protects consumers and purchasers from excessive increases in generic prescription drug prices, requires a drug manufacture to use a price increase notification form when there is an increase in the wholesale acquisition cost of a generic drug by a 100% at any one time or in the aggregate in any twelve-month period. Requires the prescription drug program to review the price increase and determine if it is excessive.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment